Lot-to-Lot Consistency Clinical Trial of Recombinant Human Papillomavirus 9-valent (Types 6/11/16/18/31/33/45/52/58) Vaccine (Escherichia Coli)

NCT07668271 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

720

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection by Human Papilloma Virus

Interventions

BIOLOGICAL: 9-valent HPV vaccine (Cecolin 9)

Sponsor

Xiamen Innovax Biotech Co., Ltd